Operating revenue rose 2% to $264.4m and net profit after tax increased 27% to $7.2m year-over-year. Medical Division outperformed with 6% revenue growth and 42% higher operating profit, while Pharmacy Division faced margin pressure.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.